throbber

`
`
`
`
`
`
`
`
`
`1510196
`
`
`
`
`
`
`
`UNITED STATES OF AMERICA
`BEFORE THE FEDERAL TRADE COMMISSION
`
`
`COMMISSIONERS:
`
`
`
`
`
`
`
`
`
`
`
`Edith Ramirez, Chairwoman
`Maureen K. Ohlhausen
`Terrell McSweeny
`
`________________________________________________
`
`
`
`
`
`
`
`
`)
`In the Matter of
`
`
`
`
`
`)
`
`
`
`
`
`
`
`
`) PUBLIC VERSION
`TEVA PHARMACEUTICAL INDUSTRIES LTD.,
`)
`
`
`a corporation;
`
`
`
`
`)
`
`
`
`
`
`
`
`
`)
`and
`
`
`
`
`
`
`
`) Docket No. C-4589
`
`
`
`
`
`
`
`
`)
`ALLERGAN PLC,
`
`
`
`
`
`)
`
`a corporation.
`
`
`
`
`)
`________________________________________________)
`
`
`
`COMPLAINT
`
`Pursuant to the Clayton Act and the Federal Trade Commission Act (“FTC Act”), and its
`authority thereunder, the Federal Trade Commission (“Commission”), having reason to believe
`that Teva Pharmaceutical Industries Ltd. (“Teva”), a corporation subject to the jurisdiction of the
`Commission, has made an offer to acquire the voting securities of certain entities and related
`assets from Allergan plc (“Allergan”), a corporation subject to the jurisdiction of the
`Commission, in violation of Section 5 of the FTC Act, as amended, 15 U.S.C. § 45, that such
`acquisition, if consummated, would violate Section 7 of the Clayton Act, as amended, 15 U.S.C.
`§ 18, and Section 5 of the FTC Act, as amended, 15 U.S.C. § 45, and it appearing to the
`Commission that a proceeding in respect thereof would be in the public interest, hereby issues its
`Complaint, stating its charges as follows:
`
`
`I. RESPONDENTS
`
`
`
`Respondent Teva is a corporation organized, existing, and doing business under
`1.
`and by virtue of the laws of Israel with its principal executive offices located at 5 Basel Street,
`P.O. Box 3190, Petach Tikva 4951033, Israel, and its United States address as follows: General
`Counsel, Teva Pharmaceutical Industries Ltd., c/o Teva North America, 425 Privet Road,
`Horsham, Pennsylvania 19044.
`
`Respondent Allergan is a corporation organized, existing, and doing business
`2.
`under and by virtue of the laws of the Republic of Ireland with its principal executive offices
`located at Clonshaugh Business and Technology Park, Coolock Dublin, D17 E400, Ireland, and
`
`
`
`1
`
`MonoSol2007-0001
`
`Dr. Reddys v. MonoSol
`IPR2016-01112
`
`

`

`its United States address as follows: Chief Legal Officer, Allergan plc, Morris Corporate Center
`III, 400 Interpace Parkway, Parsippany, New Jersey 07054.
`
`
`II. THE PROPOSED ACQUISITION
`
`
`
`On July 26, 2015, Teva proposed to acquire Allergan’s generic pharmaceutical
`3.
`business for approximately $40.5 billion (the “Acquisition”).
`
`
`III. THE RELEVANT PRODUCT MARKETS
`
`
`U.S. Food and Drug Administration (“FDA”) marketing approvals for generic
`4.
`pharmaceutical products are based on establishing bioequivalence to already approved drugs.
`When such bioequivalence is demonstrated by in vivo or in vitro studies, the FDA designates
`such generic drugs as “AB-rated” to the branded product, which allows for automatic
`substitution of the generic equivalent for the branded drug when the drug is dispensed at the
`pharmacy. Where only one AB-rated generic drug is approved, it competes against the branded
`drug. Where multiple AB-rated generic drugs are approved, they compete against each other in a
`“generic” market, which typically does not include the branded product. Generic drugs that are
`AB-rated to different branded drugs are not substitutable, even if they contain the same active
`ingredients in the same proportions in the same dosage form. For the purposes of this
`Complaint, relevant lines of commerce in which to analyze the effects of the Acquisition are the
`development, license, manufacture, marketing, distribution, and sale of the following finished
`dosage form pharmaceutical products:
`
`a.
`
`generic acitretin capsules;
`
`generic alendronate sodium tablets;
`
`generic amphetamine asparte/amphetamine sulfate/dextroamphetamine
`saccharate/dextroamphetamine sulfate extended release tablets;
`
`armodafinil tablets;
`
`generic aspirin/dipyridamole extended release capsules;
`
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx;
`
`generic benzoyl peroxide/clindamycin phosphate topical gel;
`
`generic budesonide inhalation suspension;
`
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx;
`
`generic buprenorphine HCl/naloxone HCl buccal film;
`
`generic buspirone hydrochloride tablets;
`
`b.
`
`c.
`
`
`d.
`
`e.
`
`f.
`
`g.
`
`h.
`
`i.
`
`j.
`
`k.
`
`
`
`2
`
`MonoSol2007-0002
`
`

`

`
`l.
`
`m.
`
`n.
`
`o.
`
`p.
`
`q.
`
`r.
`
`s.
`
`t.
`
`
`u.
`
`v.
`
`w.
`
`x.
`
`
`y.
`
`z.
`
`aa.
`
`bb.
`
`cc.
`
`dd.
`
`ee.
`
`ff.
`
`gg.
`
`generic carbidopa/levodopa tablets;
`
`generic clarithromycin extended release tablets;
`
`generic clonidine HCl transdermal film;
`
`generic clozapine tablets;
`
`generic cyclosporine capsules;
`
`generic cyclosporine oral solution;
`
`generic desmopressin acetate tablets;
`
`generic desogestrel/ethinyl estradiol tablets (AB-rated to Cyclessa);
`
`generic desogestrel/ethinyl estradiol and ethinyl estradiol tablets (AB-rated to
`Mircette);
`
`generic dexmethylphenidate HCl extended release capsules;
`
`generic dextroamphetamine sulfate extended release capsules;
`
`generic diazepam tablets;
`
`generic dienogest/estradiol valerate and estradiol valerate tablets (AB-rated to
`Natazia);
`
`generic disopyramide phosphate capsules;
`
`generic drospirenone/ethinyl estradiol tablets (AB-rated to Yasmin-28);
`
`generic epirubicin injection;
`
`generic estazolam tablets;
`
`generic estradiol tablets;
`
`generic ethinyl estradiol/ethynodiol diacetate tablets (AB-rated to Demulen 1/35);
`
`generic ethinyl estradiol/etonogestrel vaginal rings;
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Alesse-28);
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Levlite-28);
`
`
`
`3
`
`MonoSol2007-0003
`
`

`

`hh.
`
`ii.
`
`jj.
`
`kk.
`
`ll.
`
`nn.
`
`oo.
`
`pp.
`
`qq.
`
`rr.
`
`ss.
`
`tt.
`
`uu.
`
`vv.
`
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Lo Seasonique);
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Nordette);
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Seasonique);
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Triphasil-28);
`
`generic ethinyl estradiol/levonorgestrel tablets (AB-rated to Quartette);
`
`mm. generic ethinyl estradiol/norethindrone tablets (AB-rated to Modicon-28);
`
`generic ethinyl estradiol/norethindrone tablets (AB-rated to Tri-Norinyl 28-Day);
`
`generic ethinyl estradiol/norethindrone acetate tablets (AB-rated to Loestrin 21
`1/20);
`
`generic ethinyl estradiol/norethindrone acetate tablets (AB-rated to Loestrin 21
`1.5/30);
`
`generic ethinyl estradiol/norethindrone acetate/ferrous fumarate tablets (AB-rated
`to Estrostep FE);
`
`generic ethinyl estradiol/norethindrone acetate/ferrous fumarate tablets (AB-rated
`to Loestrin FE 1/20);
`
`generic ethinyl estradiol/norethindrone acetate/ferrous fumarate tablets (AB-rated
`to Loestrin FE 1.5/30);
`
`generic ethinyl estradiol/norgestrel tablets (AB-rated to Lo/Ovral);
`
`generic ezetimibe/simvastatin tablets;
`
`generic fentanyl buccal tablets;
`
`generic fludarabine injection;
`
`generic fluocinonide cream;
`
`generic fluocinonide cream, emulsified base;
`
`generic flutamide capsules;
`
`generic glyburide/metformin HCl tablets;
`
`
`ww.
`
`xx.
`
`yy.
`
`zz.
`
`aaa.
`
`
`
`4
`
`MonoSol2007-0004
`
`

`

`bbb. generic griseofulvin microcrystalline liquid suspension;
`
`generic hydroxyzine pamoate capsules;
`
`eee.
`
`fff.
`
`ccc.
`
`ddd. generic imiquimod topical cream;
`
`generic levalbuterol HCl inhalation solution;
`
`generic metformin HCl/saxagliptin extended release tablets;
`
`ggg. generic methotrexate injection;
`
`hhh. generic methylphenidate HCl extended release tablets;
`
`generic methylphenidate HCl extended release capsules;
`
`generic metoclopramide HCl tablets;
`
`kkk. generic minocycline capsules;
`
`generic mirtazapine oral disintegrating tablets;
`
`mmm. generic NAB paclitaxel injection;
`
`nnn. generic nabumetone tablets;
`
`ooo. generic nitrofurantoin capsules;
`
`ppp. generic norethindrone tablets (AB-rated to Micronor 28);
`
`qqq. generic norethindrone tablets (AB-rated to Nor-QD);
`
`generic nortriptyline HCl capsules;
`
`generic phentermine HCl/topiramate extended release capsules;
`
`generic propofol injection emulsion;
`
`uuu. generic propranolol HCl tablets;
`
`vvv. generic ramelteon tablets;
`
`www. generic rotigotine transdermal patch;
`
`xxx. generic tamoxifen citrate tablets;
`
`
`iii.
`
`jjj.
`
`lll.
`
`rrr.
`
`sss.
`
`ttt.
`
`
`
`5
`
`MonoSol2007-0005
`
`

`

`yyy. generic tobramycin inhalation solution;
`
`generic trimethoprim tablets; and
`
`trimipramine maleate capsules.
`
`aaaa.
`
`zzz.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Additional relevant lines of commerce in which to analyze the effects of the
`5.
`Acquisition, for the purposes of this Complaint, are the development, manufacture, distribution,
`and sale of the following FDA-approved, finished dosage form pharmaceutical products:
`
`
`a.
`
`b.
`
`betamethasone dipropionate augmented ointment;
`
`betamethasone dipropionate cream;
`
`c.
`
`d.
`
`e.
`
`f.
`
`g.
`
`h.
`
`i.
`
`j.
`
`k.
`
`l.
`
`m.
`
`n.
`
`o.
`
`betamethasone dipropionate lotion;
`
`betamethasone dipropionate ointment;
`
`betamethasone valerate cream;
`
`betamethasone valerate ointment;
`
`clobetasol propionate shampoo;
`
`clobetasol propionate ointment;
`
`desonide cream;
`
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx;
`
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx;
`
`probenecid tablets;
`
`colchicine/probenecid tablets;
`
`nystatin/triamcinolone acetonide cream; and
`
`nystatin/triamcinolone acetonide ointment.
`
`
`
`6
`
`MonoSol2007-0006
`
`

`

`
`
`IV. THE RELEVANT GEOGRAPHIC MARKETS
`
`
`With respect to the lines of commerce set forth in Paragraphs 4 and 5, the United
`6.
`States is the relevant geographic market in which to assess the competitive effects of the
`Acquisition.
`
`
`V. THE STRUCTURE OF THE MARKETS
`
`The structures of the relevant finished dosage form pharmaceutical product
`7.
`markets set forth in Paragraph 4 are described below:
`
`
`a.
`
`Acitretin capsules are retinoids used to treat psoriasis. Three firms—Allergan,
`Teva, and SigmaPharm Laboratories—supply 17.5 mg generic acitretin capsules.
`Mylan Inc. (“Mylan”) is the only other firm that holds an approved Abbreviated
`New Drug Application (“ANDA”) for 17.5 mg generic acitriten capsules. The
`Acquisition would consolidate the 17.5 mg capsule market from four to three
`suppliers. Five firms supply 10 mg and 25 mg generic acitretin capsules:
`Allergan, Teva, Mylan, Prasco Laboratories (“Prasco”), and SigmaPharm
`Laboratories. The Acquisition would reduce the number of suppliers in the 10 mg
`and 25 mg generic acitretin markets from five to four.
`
`b.
`
`
`c.
`
`
`d.
`
`
`e.
`
`Alendronate sodium tablets are used to treat osteoporosis. Five firms supply 35
`mg generic alendronate sodium tablets: Allergan, Teva, Cipla Ltd. (“Cipla”), Sun
`Pharmaceuticals Industries, Inc. (“Sun”), and Virtus Pharmaceuticals. The
`Acquisition would reduce the number of suppliers of 35 mg generic alendronate
`sodium tablets from five to four.
`
`Amphetamine aspartate/amphetamine sulfate/dextroamphetamine
`saccharate/dextroamphetamine sulfate extended release tablets are used to treat
`Attention Deficit Hyperactivity Disorder (“ADHD”). Three firms hold ANDAs
`for 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg strength tablets: Allergan,
`Teva, and Impax Laboratories, Inc. (“Impax”). Accounting for expected future
`entry, the Acquisition would reduce the number of suppliers from four to three.
`
`Armodafinil tablets are used to treat excessive sleepiness. Teva owns and
`markets the branded product, Nuvigil. Allergan recently entered the 200 mg
`generic armodafinil market as the exclusive first-to-file generic. The Acquisition
`would reduce the number of suppliers for 200 mg armodafinil tablets from two to
`one.
`
`Aspirin/dipyridamole extended release capsules are used to prevent strokes in
`people who have blood flow disorders or a history of blood clots. Teva markets
`an authorized generic and is the only supplier of generic 25 mg/200 mg
`aspirin/dipyridamole extended release capsules. Allergan is one of a limited
`number of suppliers likely to enter the generic 25 mg/200 mg
`
`7
`
`
`
`
`
`MonoSol2007-0007
`
`

`

`aspirin/dipyridamole extended release capsule market in the near future. The
`Acquisition would reduce the number of likely future suppliers for generic 25
`mg/200 mg aspirin/dipyridamole extended release capsule in the near future.
`
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`
`Benzoyl peroxide/clindamycin phosphate topical gel is a combination
`antiseptic/antibiotic used to treat acne. There are two suppliers of 5%/1%
`strength benzoyl peroxide/clindamycin phosphate gel, Mylan and Perrigo
`Company plc (“Perrigo”). Teva participates in the market through a partnership
`agreement with Perrigo. Allergan is one of a limited number of suppliers likely to
`enter the generic benzoyl peroxide/clindamycin phosphate topical gel market in
`the near future. The Acquisition would reduce the number of likely future
`suppliers for generic benzoyl peroxide/clindamycin phosphate topical gel in the
`near future.
`
`Budesonide inhalation suspension is a steroid inhalant used for the maintenance
`treatment of asthma and as prophylactic therapy in children. Only three firms
`supply 0.25 mg/2 mL and 0.5 mg/2 mL dosage strengths: Allergan, Teva, and
`Sandoz, Inc. (“Sandoz”). The Acquisition would reduce the number of firms
`supplying 0.25 mg/2 mL and 0.5 mg/2 mL dosage strengths of generic budesonide
`inhalation suspensions from three to two. Teva and Sandoz hold approved
`ANDAs for 1 mg/2 mL generic budesonide inhalant suspension. Allergan is the
`only supplier entering the 1 mg/2 mL generic budesonide inhalation suspension
`market in the near future. The acquisition would reduce the number of likely
`future suppliers of generic budesonide inhalation suspension from three to two in
`the 1 mg/2 mL strength.
`
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
`
`Buprenorphine HCl/naloxone HCl buccal film is used to treat opioid dependence.
`Teva and Allergan are two of a limited number of suppliers likely to enter the
`market for generic buprenorphine HCl/naloxone HCl buccal film in the near
`future. The Acquisition would reduce the number of likely future suppliers for
`generic buprenorphine HCl/naloxone HCl buccal film.
`
`
`f.
`
`
`g.
`
`
`h.
`
`
`i.
`
`
`j.
`
`
`
`
`
`8
`
`MonoSol2007-0008
`
`

`

`k.
`
`
`l.
`
`
`m.
`
`
`n.
`
`
`o.
`
`
`p.
`
`
`q.
`
`
`
`Buspirone hydrochloride tablets are used to treat anxiety. Four suppliers provide
`15 mg generic buspirone hydrochloride tablets: Allergan, Teva, Mylan, and
`Zydus Pharmaceuticals, Inc. (“Zydus”). Accounting for expected entry in the
`near future, the Acquisition would reduce the number of likely future suppliers of
`15 mg generic buspirone hydrochloride tablets from five to four.
`
`Carbidopa/levodopa tablets are used to treat Parkinson’s disease. Four firms hold
`approved ANDAs for generic carbidopa/levodopa tablets in the 10 mg/100 mg, 25
`mg/100 mg, and 25 mg/250 mg strengths: Allergan, Teva, Mylan, and Sun. The
`Acquisition would reduce the number of suppliers from four to three.
`
`Clarithromycin extended release tablets are used to treat various bacterial
`infections. Allergan and Teva are the only firms that supply generic
`clarithromycin extended release tablets in the 500 mg strength. Accounting for
`expected entry in the near future, the Acquisition would reduce the number of
`likely future suppliers of generic clarithromycin 500 mg tablets from three to two.
`
`Clonidine HCl transdermal film is an alpha-agonist hypotensive agent used to
`treat high blood pressure. Allergan, Teva, and Mylan are the only three firms
`supplying generic clonidine HCl transdermal film in the 0.1 mg, 0.2 mg, and 0.3
`mg per 24-hour strengths. The Acquisition would reduce the number of firms
`supplying generic clonidine HCl transdermal film from three to two.
`
`Clozapine tablets are used to treat schizophrenia. Four firms supply 25 mg and
`100 mg generic clozapine tablets: Allergan, Teva, Mylan, and Sun. Accounting
`for expected entry, the Acquisition would reduce the number of suppliers for 25
`mg and 100 mg generic clozapine tablets from five to four. Teva and Mylan are
`the only FDA-approved suppliers of 200 mg generic clozapine tablets. Allergan
`is one of a limited number of suppliers likely to enter the 200 mg generic
`clozapine tablet market in the near future. The Acquisition would reduce the
`number of likely future suppliers of generic clozapine tablets in the 200 mg
`strength market in the near future.
`
`Cyclosporine capsules are used to prevent organ rejection after a transplant. Four
`firms supply generic cyclosporine oral capsules in the 25 mg and 100 mg
`strengths: Allergan, Teva, AbbVie, Inc. (“AbbVie”), and Sandoz. The
`Acquisition would reduce the number of suppliers of generic cyclosporine
`capsules from four to three in the 25 mg and 100 mg strength markets.
`
`Cyclosporine oral solution is used to prevent organ rejection after a transplant.
`Only three firms hold ANDAs for 100 mg/mL generic cyclosporine oral solution:
`Allergan, Teva, and AbbVie. The Acquisition would reduce the number of
`suppliers of 100 mg/mL generic cyclosporine oral solution from three to two.
`
`
`
`9
`
`
`
`
`
`MonoSol2007-0009
`
`

`

`r.
`
`
`s.
`
`
`t.
`
`
`u.
`
`
`
`v.
`
`
`w.
`
`
`
`Desmopressin acetate tablets are used to treat bedwetting, clotting disorders, and a
`form of diabetes that causes excessive urination. Three firms supply 0.1 mg
`generic desmopressin acetate tablets: Allergan, Teva, and Glenmark
`Pharmaceuticals Ltd. (“Glenmark”). The Acquisition would reduce the number of
`firms supplying the 0.1 mg strength market from three to two. Four firms supply
`0.2 mg generic desmopressin acetate tablets: Allergan, Teva, Glenmark, and
`Mylan. The Acquisition would reduce the number of suppliers of the 0.2 mg
`strength tablet from four to three.
`
`Desogestrel/ethinyl estradiol tablets (AB-rated to Cyclessa) are oral
`contraceptives used to prevent pregnancy. Allergan and Teva are the only firms
`that have approved ANDAs. Allergan sells its product as a branded generic under
`the name Caziant. The Acquisition would create a monopoly in the market for
`generic desogestrel/ethinyl estradiol tablets.
`
`Desogestrel/ethinyl estradiol and ethinyl estradiol tablets (AB-rated to Mircette)
`are oral contraceptives used to prevent pregnancy. There are three competitively
`significant generic suppliers: Teva, Allergan, and Glenmark. Other firms
`approved to market the product have negligible sales and market presence.
`Allergan sells its product as a branded generic under the name Azurette. The
`Acquisition would reduce the number of competitively significant suppliers from
`three to two.
`
`Dexmethylphenidate HCl extended release capsules are used to treat ADHD.
`Four firms—Allergan, Teva, Sandoz, and Mylan—market 5 mg, 10 mg, and 20
`mg strength generic dexmethylphenidate HCl extended release capsules. The
`Acquisition would reduce the number of suppliers of 5 mg, 10 mg, and 20 mg
`strength generic dexmethylphenidate HCl extended release capsules from four to
`three. Teva and Allergan are two of a limited number of suppliers likely to enter
`the market for 25 mg and 35 mg strength generic dexmethylphenidate HCl
`extended release capsules in the near future. The Acquisition would reduce the
`number of likely future suppliers for 25 mg and 35 mg strength generic
`dexmethylphenidate HCl extended release capsules.
`
`Dextroamphetamine sulfate extended release capsules are used to treat ADHD.
`Four companies supply generic dextroamphetamine sulfate extended release
`capsules: Allergan, Teva, Mallinckrodt, LLC, and Impax. The Acquisition would
`reduce the number of suppliers from four to three.
`
`Diazepam tablets are used to treat anxiety. Four firms hold ANDAs for 2 mg, 5
`mg, and 10 mg generic diazepam tablets: Allergan, Teva, Endo International plc
`(“Endo”), and Mylan. The Acquisition would reduce the number of suppliers
`from four to three.
`
`
`
`10
`
`
`
`
`
`MonoSol2007-0010
`
`

`

`x.
`
`
`y.
`
`
`z.
`
`
`aa.
`
`
`bb.
`
`
`cc.
`
`
`dd.
`
`
`ee.
`
`Dienogest/estradiol valerate and estradiol valerate tablets (AB-rated to Natazia)
`are oral contraceptives used to prevent pregnancy. Teva and Allergan are two of
`a limited number of suppliers likely to enter the market for generic
`dienogest/estradiol valerate and estradiol valerate tablets in the near future. The
`Acquisition would reduce the number of likely future suppliers.
`
`Disopyramide phosphate capsules are used to treat abnormal heart rhythms.
`Allergan and Teva are the only two firms that hold ANDAs for 100 mg and 150
`mg generic disopyramide phosphate capsules. Accounting for expected generic
`entry, the Acquisition would reduce the number of likely future suppliers from
`three to two.
`
`Drospirenone/ethinyl estradiol tablets (AB-rated to Yasmin-28) are oral
`contraceptives used to prevent pregnancy. There are five competitively
`significant suppliers of Drospirenone/ethinyl estradiol tablets: Allergan, Teva,
`Lupin Ltd. (“Lupin”), Sandoz, and Glenmark. Other firms approved to market the
`product have negligible sales and market presence. Allergan sells its product as a
`branded generic under the name Zarah. The Acquisition would reduce the
`number of competitively significant competitors from five to four.
`
`Epirubicin injection is an anthracycline drug used in chemotherapy for the
`treatment of breast cancer. There are four suppliers of generic epirubicin
`injection in the 50 mg/25mL and 200 mg/100mL size vials: Allergan, Teva, Cipla
`and Hospira, Inc. (“Hospira”), the generic injectable division of Pfizer Inc. The
`Acquisition would reduce the number of suppliers from four to three.
`
`Estazolam tablets are used for the short-term treatment of sleep disorders. Teva
`and Allergan are the only two suppliers for 1 mg and 2 mg generic estazolam
`tablets. The Acquisition would create a monopoly in the market for generic
`estazolam tablets.
`
`Estradiol tablets are used to treat symptoms caused by menopause or removal of
`the ovaries. Three firms sell 0.5 mg, 1 mg, and 2 mg generic estradiol tablets:
`Allergan, Teva, and Mylan. The Acquisition would reduce the number of
`suppliers from three to two.
`
`Ethinyl estradiol/ethynodiol diacetate tablets (AB-rated to Demulen 1/35) are oral
`contraceptives used to prevent pregnancy. Teva and Allergan are the only generic
`suppliers. Allergan sells its product as a branded generic under the name Zovia.
`The Acquisition would create a monopoly in the market for generic ethinyl
`estradiol/ethynodiol diacetate tablets.
`
`Ethinyl estradiol/etonogestrel vaginal rings are contraceptives used to prevent
`pregnancy. Teva and Allergan are two of a limited number of suppliers likely to
`enter the market in the near future. The Acquisition would reduce the number of
`likely future suppliers for generic ethinyl estradiol/etonogestrel vaginal rings.
`
`
`
`11
`
`MonoSol2007-0011
`
`

`

`
`ff.
`
`
`gg.
`
`
`hh.
`
`
`ii.
`
`
`jj.
`
`
`kk.
`
`
`ll.
`
`
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Alesse-28) are oral
`contraceptives used to prevent pregnancy. Five firms supply generic Alesse-28:
`Allergan, Teva, Endo, Lupin, and Sandoz. Allergan sells its product as a branded
`generic under the name Lutera. The Acquisition would reduce the number of
`suppliers from five to four.
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Levlite-28) are oral
`contraceptives used to prevent pregnancy. Three firms have ANDAs approved
`for generic Levlite-28: Allergan, Teva, and Mylan. Allergan sells its product as a
`branded generic under the name Sronyx. The Acquisition would reduce the
`number of suppliers from three to two.
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Lo Seasonique) are oral
`contraceptives used to prevent pregnancy. Teva owns the branded product and
`markets an authorized generic. Allergan and Lupin market generic products,
`which compete directly with Teva’s authorized generic. Allergan sells its product
`as a branded generic under the name Amethia Lo. Accounting for expected entry,
`the Acquisition would reduce the number of suppliers from four to three.
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Nordette) are oral
`contraceptives used to prevent pregnancy. There are five competitively
`significant suppliers of generic Nordette: Allergan, Teva, Sandoz, Glenmark, and
`Mylan. Allergan sells its product as a branded generic under the name Levora.
`The Acquisition would reduce the number of suppliers from five to four.
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Seasonique) are oral
`contraceptives used to prevent pregnancy. Teva owns the branded product and
`markets an authorized generic. Four additional firms supply generic Seasonique:
`Allergan, Glenmark, Lupin, and Mylan. Allergan sells its product as a branded
`generic under the name Amethia. The Acquisition would reduce the number of
`suppliers from five to four.
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Triphasil-28) are oral
`contraceptives used to prevent pregnancy. Three firms supply generic Triphasil-
`28: Allergan, Teva, and Endo. Allergan sells its product as a branded generic
`under the name Trivora. The Acquisition would reduce the number of suppliers
`from three to two.
`
`Ethinyl estradiol/levonorgestrel tablets (AB-rated to Quartette) are oral
`contraceptives used to prevent pregnancy. Teva and Allergan are two of a limited
`number of suppliers likely to enter the market for generic Quartette in the near
`future. The Acquisition would reduce the number of likely future suppliers for
`generic Quartette.
`
`
`
`12
`
`MonoSol2007-0012
`
`

`

`mm. Ethinyl estradiol/norethindrone tablets (AB-rated to Modicon-28) are oral
`contraceptives used to prevent pregnancy. Allergan, Teva, and Mylan market
`generic Modicon-28. Allergan sells its product as a branded generic under the
`name Necon. The Acquisition would reduce the number of suppliers from three
`to two.
`
`Ethinyl estradiol/norethindrone tablets (AB-rated to Tri-Norinyl 28-Day) are oral
`contraceptives used to prevent pregnancy. Allergan markets branded Tri-Norinyl
`28-Day and an authorized generic, which Allergan sells under the name Leena,
`and Teva markets the only generic version. The Acquisition would reduce the
`number of suppliers from two to one.
`
`Ethinyl estradiol/norethindrone acetate tablets (AB-rated to Loestrin 21 1/20) are
`oral contraceptives used to prevent pregnancy. There are four suppliers of generic
`Loestrin 21 1/20: Allergan, Teva, Mylan, and Endo. Allergan sells its product as
`a branded generic under the name Microgestin 1/20. The Acquisition would
`reduce the number of suppliers from four to three.
`
`Ethinyl estradiol/norethindrone acetate tablets (AB-rated to Loestrin 21 1.5/30)
`are oral contraceptives used to prevent pregnancy. Four firms market generic
`Loestrin 21 1.5/30: Allergan, Teva, Mylan, and Endo. Allergan sells its product
`as a branded generic under the name Microgestin 1.5/30. The Acquisition would
`reduce the number of suppliers from four to three.
`
`Ethinyl estradiol/norethindrone acetate/ferrous fumarate tablets (AB-rated to
`Estrostep FE) are oral contraceptives used to prevent pregnancy. Teva and
`Allergan, which markets branded Estrostep FE and an authorized generic, are the
`only suppliers of generic Estrostep FE. Allergan sells its product as a branded
`generic under the name Tilia Fe. Thus, the Acquisition would create a monopoly
`in the generic Estrostep FE market.
`
`Ethinyl estradiol/norethindrone acetate/ferrous fumarate tablets (AB-rated to
`Loestrin FE 1/20) are oral contraceptives used to prevent pregnancy. Five firms
`supply generic Loestrin FE 1/20: Allergan, Teva, Endo, Mylan, and Lupin.
`Allergan sells its product as a branded generic under the name Microgestin Fe
`1/20. The Acquisition would reduce the number of suppliers from five to four.
`
`Ethinyl estradiol/norethindrone acetate/ferrous fumarate tablets (AB-rated to
`Loestrin FE 1.5/30) are oral contraceptives used to prevent pregnancy. Five firms
`supply generic Loestrin FE 1.5/30: Allergan, Teva, Endo, Lupin, and Mylan.
`Allergan sells its product as a branded generic under the name Microgestin Fe
`1.5/30. The Acquisition would reduce the number of suppliers from five to four.
`
`Ethinyl estradiol/norgestrel tablets (AB-rated to Lo/Ovral) are an oral
`contraceptive drug used to prevent pregnancy. Allergan and Teva are the only
`current suppliers of generic ethinyl estradiol/norgestrel tablets. Allergan sells its
`
`
`nn.
`
`
`oo.
`
`
`pp.
`
`
`qq.
`
`
`rr.
`
`
`ss.
`
`
`tt.
`
`
`
`13
`
`MonoSol2007-0013
`
`

`

`product as a branded generic under the name Low-Ogestrel. Accounting for
`future entry, the Acquisition would reduce the number of current and likely future
`suppliers from three to two.
`
`Ezetimibe/simvastatin tablets are used to treat high cholesterol. Teva and
`Allergan are among a limited number of likely future suppliers of generic
`ezetimibe/simvastatin tablets in the 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg,
`and 10 mg/80 mg strengths. The Acquisition would reduce the number of likely
`future suppliers for generic ezetimibe/simvastatin tablets.
`
`Fentanyl buccal tablets are used to treat severe pain. Teva markets the branded
`product, Fentora, and plans to launch an authorized generic product. Allergan is
`one of a limited number of future generic fentanyl buccal tablet suppliers. The
`Acquisition would reduce the number of likely future suppliers for generic
`fentanyl buccal tablets.
`
`
`ww. Fludarabine injection is a chemotherapy drug used to treat chronic lymphocytic
`leukemia. There are only three independent suppliers of 50 mg lyophilized vials:
`Allergan, Teva, and Hospira. The Acquisition would reduce the number of
`independent suppliers from three to two.
`
`
`uu.
`
`
`vv.
`
`
`xx.
`
`
`yy.
`
`
`zz.
`
`Fluocinonide cream is a steroid used as an anti-inflammatory for the treatment of
`skin disorders. Three firms market 0.05% generic fluocinonide cream: Teva,
`Allergan, and Sun, owner of the branded product, which sells an authorized
`generic. The Acquisition would reduce the number of suppliers from three to
`two.
`
`Fluocinonide cream, emulsified base is a steroid used as an anti-inflammatory for
`the treatment of skin disorders. Only two firms market 0.05% generic
`fluocinonide emulsified base cream: Teva and Taro, which sells an authorized
`generic. Allergan is the only supplier likely to enter the market in the near future.
`The acquisition would reduce the number of likely future suppliers of 0.05%
`generic fluocinonide emulsified base cream from three to two.
`
`Flutamide capsules are used in hormone-based chemotherapy for the treatment of
`prostate cancer. Three firms supply 125 mg generic flutamide capsules:
`Allergan, Teva, and Endo. The Acquisition would reduce the number of suppliers
`from three to two.
`
`
`aaa. Glyburide/metformin HCl tablets are used to treat high blood sugar levels caused
`by type-2 diabetes. There are four independent suppliers of 1.25/250 mg, 2.5/500
`mg, and 5/500 mg generic glyburide/metformin HCl tablets: Allergan, Teva,
`Aurobindo Pharma Ltd. (“Aurobindo”), and Heritage Pharmaceuticals Inc.
`(“Heritage”). The Acquisition would reduce the number of suppliers from four to
`three.
`
`
`
`
`
`14
`
`MonoSol2007-0014
`
`

`

`bbb. Griseofulvin microcrystalline liquid suspension is used to treat fungal infections
`of the skin, hair, and nails. Allergan, Teva, and Endo supply 125 mg/5mL generic
`griseofulvi

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket